Prevalence of drug resistance mutations in HIV-1 protease gene from North India

被引：0
|
作者：
Mohd Azam
Abida Malik
Meher Rizvi
Supriya Singh
Hanu Ram
Megha Singhal
Poonam Gupta
机构：
[1] J. N. Medical College,Department of Microbiology
[2] Aligarh Muslim University,Division of Biochemistry & Biotechnology
[3] National Centre for Disease Control,undefined
来源：
BMC Infectious Diseases | / 12卷 / Suppl 1期
关键词：
Protease Gene; Drug Resistance Mutation; Line Drug; Mutation M46I; Good Therapeutic Outcome;
D O I：
10.1186/1471-2334-12-S1-P84
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Clinical significance of HIV-1 drug resistance mutations
    Wagner, Thor A.
    Frenkel, Lisa M.
    LABMEDICINE, 2006, 37 (09): : 554 - 561
  • [42] Structural and thermodynamic escape mechanism from drug resistant mutations of HIV-1 protease
    Velazquez-Campoy, A
    Vega, S
    Kang, LW
    Kiso, Y
    Amzel, M
    Freire, E
    BIOPHYSICAL JOURNAL, 2003, 84 (02) : 504A - 504A
  • [43] Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, US-2006
    Wheeler, William H.
    Ziebell, Rebecca A.
    Zabina, Helena
    Pieniazek, Danuta
    Prejean, Joseph
    Bodnar, Ulana R.
    Mahle, Kristen C.
    Heneine, Walid
    Johnson, Jeffrey A.
    Hall, H. Irene
    AIDS, 2010, 24 (08) : 1203 - 1212
  • [44] DEVELOPMENT OF DRUG-RESISTANCE TO HIV-1 PROTEASE INHIBITORS
    RIDKY, T
    LEIS, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (50) : 29621 - 29623
  • [45] THE MOLECULAR BASIS OF HIV-1 PROTEASE DRUG RESISTANCE.
    Ala, Paul
    Huston, E.
    DeLoskey, R.
    Duke, J.
    Korant, B.
    Chang, C-H.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C201 - C201
  • [46] Structural mechanisms of drug resistance for HIV-1 protease mutants
    Erickson, JW
    Bhat, TN
    Munshi, S
    Gulnik, S
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 63 - 63
  • [47] Prevalence of HIV-1 transmitted drug resistance in Liberia
    Loubet, P.
    Charpentier, C.
    Visseaux, B.
    Nuta, C.
    Adu, E.
    Chapplain, J. M.
    Baysah, M.
    Walters-Doe, S.
    Tattevin, P.
    Peytavin, G.
    Yazdanpanah, Y.
    Descamps, D.
    ANTIVIRAL THERAPY, 2014, 19 : A88 - A88
  • [48] HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
    Axel Fun
    Noortje M van Maarseveen
    Jana Pokorná
    Renée EM Maas
    Pauline J Schipper
    Jan Konvalinka
    Monique Nijhuis
    Retrovirology, 8
  • [49] HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
    Fun, Axel
    van Maarseveen, Noortje M.
    Pokorna, Jana
    Maas, Renee E. M.
    Schipper, Pauline J.
    Konvalinka, Jan
    Nijhuis, Monique
    RETROVIROLOGY, 2011, 8
  • [50] Genetic Diversity and Drug Resistance Mutations in Reverse Transcriptase and Protease Genes of HIV-1 Isolates from Southwestern Siberia
    Rudometova, Nadezhda B.
    Shcherbakova, Nadezhda S.
    Shcherbakov, Dmitry N.
    Mishenova, Elena V.
    Delgado, Elena
    Ilyichev, Alexander A.
    Karpenko, Larisa I.
    Thomson, Michael M.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2021, 37 (09) : 716 - 723
12345